Ear7 Activators
Ear7, also known as Eosinophil-Associated Ribonuclease A Family Member 7, is a gene that serves a crucial role in cellular processes, particularly in the context of ribonuclease activity and RNA metabolic processes. Its primary function is to enable ribonuclease activity, participating either upstream or within the intricate machinery of RNA metabolism. This suggests a pivotal role in regulating the degradation and processing of RNA molecules, indicating the gene's involvement in the fundamental processes that maintain cellular homeostasis. The predicted localization of Ear7 within secretory granules implies a potential association with cellular compartments involved in the secretion of proteins. This localization may suggest a role in the fine-tuning of intracellular and extracellular RNA dynamics, contributing to the overall functionality of the cell. The importance of Ear7 is underscored by its involvement in these essential cellular processes, highlighting its position in the intricate network of molecular activities that govern cellular function.
Activation of Ear7 involves a sophisticated interplay of various molecular mechanisms and signaling pathways. The diverse set of chemicals presented in the table reflects the complexity of the regulatory network associated with Ear7. Indirect activators disrupt specific signaling pathways, influencing downstream events that positively impact RNA metabolic processes and contribute to the up-regulation of Ear7 expression. For instance, inhibitors targeting TGF-β receptors or Src family kinases alter key signaling cascades, ultimately affecting RNA metabolism. Histone deacetylase inhibitors, such as Valproic acid, modify chromatin structure, enhancing accessibility to the Ear7 gene locus and facilitating its up-regulation. Direct activators, like AMPK stimulators, directly influence cellular energy status, triggering events that positively modulate RNA metabolism and lead to Ear7 activation. These mechanisms collectively reveal the intricate regulatory landscape that governs the expression and function of Ear7, shedding light on its significance in cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a phosphodiesterase 4 inhibitor, indirectly activates Ear7 by elevating cAMP levels. Increased cAMP activates PKA, leading to downstream events that positively modulate RNA metabolic processes and up-regulate Ear7 expression. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2, a Src family kinase inhibitor, indirectly activates Ear7 by suppressing Src family kinases. Inhibition of these kinases influences downstream signaling events, positively impacting RNA metabolic processes and facilitating up-regulation of Ear7. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, a histone deacetylase inhibitor, indirectly activates Ear7 by promoting histone acetylation. Altered chromatin structure enhances accessibility to the Ear7 gene locus, positively influencing RNA metabolic processes and facilitating up-regulation of Ear7. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
LY2109761, a TGF-β receptor inhibitor, indirectly activates Ear7 by disrupting the TGF-β signaling pathway. This interference leads to altered downstream events that positively impact RNA metabolism, contributing to the up-regulation of Ear7 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a phosphoinositide 3-kinase inhibitor, indirectly activates Ear7 by inhibiting PI3K. This inhibition disrupts downstream signaling events, positively influencing RNA metabolic processes and facilitating up-regulation of Ear7. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR, an AMPK activator, directly activates Ear7 by stimulating AMPK. Activated AMPK modulates cellular energy status, triggering downstream events that positively influence RNA metabolic processes, leading to the up-regulation of Ear7 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, indirectly activates Ear7 by dampening the MAPK pathway. This inhibition influences downstream events related to RNA metabolism, contributing to the up-regulation of Ear7 expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763, a GSK-3 inhibitor, indirectly activates Ear7 by suppressing GSK-3 activity. Inhibition of GSK-3 influences downstream signaling events, positively impacting RNA metabolic processes and facilitating up-regulation of Ear7. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol directly activates Ear7 by modulating the SIRT1 pathway. Interaction with SIRT1 enhances its binding to the Ear7 promoter, promoting transcriptional activation and up-regulation of Ear7 expression in response to cellular stress. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542, a TGF-β receptor inhibitor, indirectly activates Ear7 by disrupting the TGF-β signaling pathway. This interference leads to altered downstream events that positively impact RNA metabolism, contributing to the up-regulation of Ear7 expression. | ||||||